These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 27887796)

  • 1. Vaccine strategies: Optimising outcomes.
    Hardt K; Bonanni P; King S; Santos JI; El-Hodhod M; Zimet GD; Preiss S
    Vaccine; 2016 Dec; 34(52):6691-6699. PubMed ID: 27887796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
    Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
    Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccine introduction--the first five years.
    Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
    Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
    MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Conflict on Immunisation Coverage in 16 Countries.
    Grundy J; Biggs BA
    Int J Health Policy Manag; 2019 Apr; 8(4):211-221. PubMed ID: 31050966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenth Technical Advisory Group (TAG) meeting on vaccine-preventable diseases.
    EPI Newsl; 1992 Apr; 14(2):2-6. PubMed ID: 12285738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
    Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G
    Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
    Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
    Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A report on the status of vaccination in Europe.
    Sheikh S; Biundo E; Courcier S; Damm O; Launay O; Maes E; Marcos C; Matthews S; Meijer C; Poscia A; Postma M; Saka O; Szucs T; Begg N
    Vaccine; 2018 Aug; 36(33):4979-4992. PubMed ID: 30037416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
    Chauke-Moagi BE; Mumba M
    Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andean region: measles on the way out.
    EPI Newsl; 1996 Oct; 18(5):1-3. PubMed ID: 12320547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.
    Jauregui B; Garcia AG; Bess Janusz C; Blau J; Munier A; Atherly D; Mvundura M; Hajjeh R; Lopman B; Clark AD; Baxter L; Hutubessy R; de Quadros C; Andrus JK
    Vaccine; 2015 May; 33 Suppl 1(0 1):A28-33. PubMed ID: 25919170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status of New Vaccine Introduction - Worldwide, September 2016.
    Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries.
    Burchett HE; Mounier-Jack S; Torres-Rueda S; Griffiths UK; Ongolo-Zogo P; Rulisa S; Edengue JM; Chavez E; Kitaw Y; Molla M; Konate M; Gelmon L; Onyango-Ouma W; Lagarde M; Mills A
    Vaccine; 2014 Nov; 32(48):6505-12. PubMed ID: 25261379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
    Owsianka B; Gańczak M
    Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.